Ain Holdings sees sales surge 39.6% in first half, driven by acquisitions

Ain Holdings reported robust consolidated operating results for the first half of fiscal year ending April 30, 2026, with net sales surging to 299,857 million yen, a 39.6% increase year-on-year. Operating profit rose by 79.1% to 10,517 million yen, and profit attributable to owners of parent increased by 39.9% to 4,494 million yen. This strong performance led to a basic earnings per share of 128.05 yen. The company's total assets also expanded significantly to 514,569 million yen as of October 31, 2025, up from 311,921 million yen at April 30, 2025.

A key driver of this growth was the acquisition of NSSK-WW Co., Ltd. (now AIN-AG1 Co., Ltd.) and its subsidiaries, including Sakura Pharmacy Group, on August 1, 2025. This business combination added 13 new entities to the consolidated scope, enhancing the dispensing pharmacy business segment and significantly increasing goodwill by 121,345 million yen in the first half of the fiscal year. This expansion aligns with the company's "Ambitious Goals 2034" vision, aiming for 1 trillion yen in net sales.

The acquisition-driven expansion also impacted the financial position, with total liabilities increasing to 369,081 million yen, primarily due to higher trade payables and borrowings for the acquisition. Despite this, the company reiterated its full fiscal year consolidated earnings forecast, anticipating net sales of 646,000 million yen and profit attributable to owners of parent of 13,500 million yen for the year ending April 30, 2026.